Moderna Is Up 109% in 2026. Jim Cramer Just Called It ‘Finally Investable Again.’ Is the Stock a No-Brainer Buy on Its Recent Pullback?
Key Points Moderna is known as a coronavirus vaccine giant, but it’s progressively becoming a multi-product company. The biotech has…